HomePRLD • NASDAQ
add
Prelude Therapeutics Inc
Previous close
$1.06
Day range
$0.98 - $1.08
Year range
$0.80 - $6.80
Market cap
56.14M USD
Avg Volume
632.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 3.00M | — |
Operating expense | 37.38M | 11.95% |
Net income | -32.27M | -5.43% |
Net profit margin | -1.08K | — |
Earnings per share | -0.43 | 4.44% |
EBITDA | -33.97M | -2.61% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 153.63M | -33.35% |
Total assets | 197.22M | -23.71% |
Total liabilities | 40.79M | 101.39% |
Total equity | 156.43M | — |
Shares outstanding | 55.04M | — |
Price to book | 0.37 | — |
Return on assets | -40.78% | — |
Return on capital | -45.83% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -32.27M | -5.43% |
Cash from operations | -27.30M | -6.28% |
Cash from investing | 10.73M | -28.66% |
Cash from financing | -131.00K | -248.86% |
Net change in cash | -16.69M | -58.24% |
Free cash flow | -16.20M | -41.08% |
About
Founded
2016
Headquarters
Website
Employees
128
